Frontiers in Pharmacology | Pharmacology of Infectious Diseases

Original Research

Published on 12 Mar 2025

Exploring the antibacterial potential of Clidemia hirta leaf extract against the pathogenicity of Pseudomonas aeruginosa: in vitro and in silico approaches

in Pharmacology of Infectious Diseases

Vignesh Murugesan
Pargovan Palanivel
Gokul Ramesh
Dwarakesh Ganesh
Helan Soundra Rani Michael
Shivakumar Bandhumy Lingam
Rathish Kumar Sivaraman

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555542

2,886 views
2 citations

Original Research

Published on 11 Mar 2025

Evaluating the influence MRSA Co-infection on 28-day mortality among sepsis patients: insights from the MIMIC-IV database

in Pharmacology of Infectious Diseases

Yi-Chang Zhao
Jia-Kai Li
Yu-kun Zhang
Zhi-Hua Sun
Rao Fu
Bi-Kui Zhang
Miao Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1534107

3,505 views
1 citation

Brief Research Report

Published on 10 Mar 2025

Omadacycline successfully treated severe Legionella pneumonia after moxifloxacin treatment failure: Case series

in Pharmacology of Infectious Diseases

Biyun Li
Laiyu Liu
Fei Li
Chunmei He
Yuan Chen
Xiaodong Tian
Zhenyu Liu
Weizhen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559857

2,755 views
2 citations

Systematic Review

Published on 28 Feb 2025

Effectiveness of pharmacological treatments for COVID-19 due to SARS-CoV-2: a systematic literature review

in Pharmacology of Infectious Diseases

Carolina Garcia Vidal
Jonathan González
Carlos Lumbreras
Miguel Salavert
Antonio Castro
Darío Rubio-Rodríguez
Carlos Rubio-Terrés

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1469681

3,810 views

Review

Published on 26 Feb 2025

Calcium phosphate-based anti-infective bone cements: recent trends and future perspectives

in Pharmacology of Infectious Diseases

Xiang Liu
Chaoli Wang
Han Wang
Guoliang Wang
Yong Zhang
Yunfei Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1522225

3,781 views
3 citations

Original Research

Published on 26 Feb 2025

Optimisation of cultivation conditions for Bacillus velezensis G7 from mangrove plants and exploration of potential bacteriocins

in Pharmacology of Infectious Diseases

Yang Li
Haotian Ma
Ruixue Pan
Yuner Long
Yining Zhao
Mengbo Yu
Jinju Peng
Yi Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1530043

2,228 views
4 citations

Original Research

Published on 26 Feb 2025

Economic impact of individualized antimicrobial dose optimization in the critically ill patient in Spain

in Pharmacology of Infectious Diseases

Santiago Grau
Sonia Luque
Olivia Ferrandez
Adela Benitez Cano
Darío Rubio-Rodríguez
Carlos Rubio-Terrés

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1506109

1,543 views

Original Research

Published on 24 Feb 2025

Association between statin administration and Clostridium difficile-induced enteritis: a retrospective analysis of the MIMIC-IV database

in Pharmacology of Infectious Diseases

Renli Wang
Rongjun Liu
Hua Wang
Zhaojun Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1550378

3,191 views
1 citation

Case Report

Published on 21 Feb 2025

Treatment of pediatric central nervous system infection caused by carbapenem-resistant Klebsiella pneumoniae with ceftazidime/avibactam, two cases report and literature review

in Pharmacology of Infectious Diseases

Lu Qing
Haiyang Zhang
Xin Pan
Zhongqiang Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532608

2,319 views
2 citations

Original Research

Published on 14 Feb 2025

Model-guided development of pharmacokinetic/pharmacodynamic cut-offs and evaluation of sitafloxacin dosing regimens against target pathogens

in Pharmacology of Infectious Diseases

Hailan Wu
Yi Li
Xin Li
Yaxin Fan
Beining Guo
Xiaofen Liu
Wanzhen Li
Mengting Chen
Yan Chen
Jing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1476158

2,042 views

Correction

Published on 14 Feb 2025

Corrigendum: Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients

in Pharmacology of Infectious Diseases

Jing Wang
Qiu Fang
Xuemei Luo
Lu Jin
Huaijun Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1565995

983 views

Original Research

Published on 04 Feb 2025

Computational and in vitro evaluation of sumac-derived ©Rutan compounds towards Sars-CoV-2 Mpro inhibition

in Pharmacology of Infectious Diseases

Muzaffar Kayumov
Parthiban Marimuthu
Jamoliddin Razzokov
Nurkhodja Mukhamedov
Akmal Asrorov
Nodir S. Berdiev
Jamolitdin F. Ziyavitdinov
Ansor Yashinov
Yuliya Oshchepkova
Shavkat Salikhov

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1518463

1,984 views
2 citations

Brief Research Report

Published on 22 Jan 2025

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients

in Pharmacology of Infectious Diseases

Ana Virseda-Berdices
Óscar Brochado-Kith
Juan Berenguer
Juan González-García
Leire Pérez-Latorre
Carmen Busca
Cristina Díez
Rafael Micán
Amanda Fernández-Rodríguez
María Ángeles Jiménez-Sousa

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1436198

1,926 views

Review

Published on 21 Jan 2025

Anti-HSV-1 agents: an update

in Pharmacology of Infectious Diseases

Wenwen Lv
Lei Zhou
Jia Wu
Jishuai Cheng
Yongzhong Duan
Wen Qian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1451083

10,890 views
6 citations

Systematic Review

Published on 20 Jan 2025

Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis

in Pharmacology of Infectious Diseases

Lu Cao
Li Li
Lixing Yang
Nan Zhou
Yu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1507117

4,351 views
5 citations

Original Research

Published on 09 Jan 2025

Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients

in Pharmacology of Infectious Diseases

Jing Wang
Qiu Fang
Xuemei Luo
Lu Jin
Huaijun Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1524272

2,328 views

Editorial

Published on 06 Jan 2025

Editorial: Novel pharmacological targets and strategies to treat neglected global diseases (NGDs): an LMIC perspective

in Pharmacology of Infectious Diseases

Kishor M. Wasan
Somia Iqtadar
Celestin Nzanzu Mudogo
Miguel Angel Chávez-Fumagalli

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1527705

1,511 views
2 citations

Original Research

Published on 03 Jan 2025

The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model

in Pharmacology of Infectious Diseases

Changjing Xu
Junlong Zhu
Kun Tu
Hui Tang
Xinxin Zhou
Qiuyu Li
Kun Chen
Xuping Yang
Yilan Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1505653

2,028 views

Original Research

Published on 03 Jan 2025

Efficacy, safety, and therapeutic drug monitoring of polymyxin B sulfate and colistin sulfate in critically ill patients: a real-world retrospective study

in Pharmacology of Infectious Diseases

Yijing Zhang
Chuhui Wang
Jiaojiao Chen
Chuqi Bai
Dan Sun
Yulan Qiu
Mengmeng Teng
Yalin Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466888

2,805 views
2 citations

Systematic Review

Published on 19 Dec 2024

Effectiveness and safety of echinocandins combination therapy with the standard of care compared to the standard of care monotherapy for the treatment of invasive aspergillosis infection: a meta-analysis

in Pharmacology of Infectious Diseases

Yazed Saleh Alsowaida
Bader Alshoumr
Shuroug A. Alowais
Khalid Bin Saleh
Alia Alshammari
Kareemah Alshurtan
Haytham A. Wali

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1500529

3,111 views
2 citations

Review

Published on 19 Dec 2024

Clade Ib: a new emerging threat in the Mpox outbreak

in Pharmacology of Infectious Diseases

Shriyansh Srivastava
Laxmi
Khyati Sharma
Sathvik Belagodu Sridhar
Sirajunisa Talath
Javedh Shareef
Rachana Mehta
Prakisini Satapathy
Ranjit Sah

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1504154

12,379 views
25 citations

Original Research

Published on 18 Dec 2024

Proteomic study of the inhibitory effects of tannic acid on MRSA biofilm

in Pharmacology of Infectious Diseases

Yang Miao
Wang Shuang
Qu Qianwei
Liu Xin
Peng Wei
Yang Hai
Zhou Yonghui
Yu Xinbo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413669

2,342 views
3 citations

Original Research

Published on 13 Dec 2024

Alhagi maurorum extract in combination with lytic phage cocktails: a promising therapeutic approach against biofilms of multi-drug resistant P. mirabilis

in Pharmacology of Infectious Diseases

Arezoo Mirzaei
Bahram Nasr Esfahani
Mustafa Ghanadian
Jeroen Wagemans
Rob Lavigne
Sharareh Moghim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1483055

2,457 views
3 citations

Original Research

Published on 12 Dec 2024

Which fluoroquinolone is safer when combined with bedaquiline for tuberculosis treatment: evidence from FDA Adverse Event Reporting System database from 2013 to 2024

in Pharmacology of Infectious Diseases

Sheng Wei
Changping He
Xiangping Xie
Anping Zhang
Simin Tang
Sha Li
Yanlang He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491921

3,631 views
1 citation

439 articles

articles

Exploring the antibacterial potential of Clidemia hirta leaf extract against the pathogenicity of Pseudomonas aeruginosa: in vitro and in silico approaches

Evaluating the influence MRSA Co-infection on 28-day mortality among sepsis patients: insights from the MIMIC-IV database

Omadacycline successfully treated severe Legionella pneumonia after moxifloxacin treatment failure: Case series

Effectiveness of pharmacological treatments for COVID-19 due to SARS-CoV-2: a systematic literature review

Calcium phosphate-based anti-infective bone cements: recent trends and future perspectives

Optimisation of cultivation conditions for Bacillus velezensis G7 from mangrove plants and exploration of potential bacteriocins

Economic impact of individualized antimicrobial dose optimization in the critically ill patient in Spain

Association between statin administration and Clostridium difficile-induced enteritis: a retrospective analysis of the MIMIC-IV database

Treatment of pediatric central nervous system infection caused by carbapenem-resistant Klebsiella pneumoniae with ceftazidime/avibactam, two cases report and literature review

Model-guided development of pharmacokinetic/pharmacodynamic cut-offs and evaluation of sitafloxacin dosing regimens against target pathogens

Corrigendum: Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients

Computational and in vitro evaluation of sumac-derived ©Rutan compounds towards Sars-CoV-2 Mpro inhibition

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients

Anti-HSV-1 agents: an update

Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis

Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients

Editorial: Novel pharmacological targets and strategies to treat neglected global diseases (NGDs): an LMIC perspective

The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model

Efficacy, safety, and therapeutic drug monitoring of polymyxin B sulfate and colistin sulfate in critically ill patients: a real-world retrospective study

Effectiveness and safety of echinocandins combination therapy with the standard of care compared to the standard of care monotherapy for the treatment of invasive aspergillosis infection: a meta-analysis

Clade Ib: a new emerging threat in the Mpox outbreak

Proteomic study of the inhibitory effects of tannic acid on MRSA biofilm

Alhagi maurorum extract in combination with lytic phage cocktails: a promising therapeutic approach against biofilms of multi-drug resistant P. mirabilis

Which fluoroquinolone is safer when combined with bedaquiline for tuberculosis treatment: evidence from FDA Adverse Event Reporting System database from 2013 to 2024